BUB +40.21%: the infant formula company received FDA approval to sell tins into the US market today. America has been battling a shortage in infant formula after several brands were forced to recall products that had led to bacterial infections in a number of kids while supply chain issues have compounded the problem. As a result, the FDA fast-tracked the process to have seven of Bubs’ products available for sale in the states with 500,000 tins ready for immediate exportation. Bubs have confirmed an additional 750,000 tins would be made available in the coming months while also looking to increase production at their FDA registered facility to triple capacity. Heading into the announcement, Bubs had around 13m shares short sold, contributing to the early spike in the share price.
scroll
Gerrish: The correction is done, we’re positioning for what comes next
Close
A discussion with Geoff Wilson – Wilson Asset Management & James Gerrish – Market Matters
Close
Friday 9th May – Dow up +254pts, SPI up +3pts
Close
Relevant suggested news and content from the site
Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.
Video
WATCH
A discussion with Geoff Wilson – Wilson Asset Management & James Gerrish – Market Matters
Recorded Monday 31st March
Podcast
LISTEN
Friday 9th May – Dow up +254pts, SPI up +3pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.
